-
Something wrong with this record ?
The Efficacy and Safety of Hybrid Ablations for Atrial Fibrillation
P. Osmancik, D. Herman, P. Kacer, V. Rizov, J. Vesela, R. Rakova, J. Karch, M. Susankova, L. Znojilova, R. Fojt, P. Prodanov, K. Kremenova, H. Malikova, T. Peisker, P. Stros, K. Curila, A. Javurkova, J. Raudenska, P. Budera
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Anti-Arrhythmia Agents therapeutic use MeSH
- Atrial Fibrillation * drug therapy surgery MeSH
- Catheter Ablation * adverse effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Tachycardia, Supraventricular * surgery MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: This study sought to comprehensively determine the procedural safety and midterm efficacy of hybrid ablations. BACKGROUND: Hybrid ablation of atrial fibrillation (AF) (thoracoscopic ablation followed by catheter ablation) has been used for patients with nonparoxysmal AF; however, accurate data regarding efficacy and safety are still limited. METHODS: Patients with nonparoxysmal AF underwent thoracoscopic, off-pump ablation using the COBRA Fusion radiofrequency system (Estech) followed by a catheter ablation 3 months afterward. The safety of the procedure was assessed using sequential brain magnetic resonance and neuropsychological examinations at baseline (1 day before), postoperatively (2-4 days for brain magnetic resonance imaging or 1 month for neuropsychological examination), and at 9 months after the surgical procedure. Implantable loop recorders were used to detect arrhythmia recurrence. Arrhythmia-free survival (the primary efficacy endpoint) was defined as no episodes of AF or atrial tachycardia while off antiarrhythmic drugs, redo ablations or cardioversions. RESULTS: Fifty-nine patients (age: 62.5 ± 10.5 years) were enrolled, 37 (62.7%) were men, and the mean follow-up was 30.3 ± 10.8 months. Thoracoscopic ablation was successfully performed in 55 (93.2%) patients. On baseline magnetic resonance imaging, chronic ischemic brain lesions were present in 60.0% of patients. New ischemic lesions on postoperative magnetic resonance imaging were present in 44.4%. Major postoperative cognitive dysfunction was present in 27.0% and 17.6% at 1 and 9 months postoperatively, respectively. The probability of arrhythmia-free survival was 54.0% (95% CI: 41.3-66.8) at 1 year and 43.8% (95% CI: 30.7-57.0) at 2 years. CONCLUSIONS: The thoracoscopic ablation is associated with a high risk of silent cerebral ischemia. The midterm efficacy of hybrid ablations is moderate.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011837
- 003
- CZ-PrNML
- 005
- 20250506102640.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jacep.2021.04.013 $2 doi
- 035 __
- $a (PubMed)34217655
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Osmancik, Pavel $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: pavel.osmancik@gmail.com
- 245 14
- $a The Efficacy and Safety of Hybrid Ablations for Atrial Fibrillation / $c P. Osmancik, D. Herman, P. Kacer, V. Rizov, J. Vesela, R. Rakova, J. Karch, M. Susankova, L. Znojilova, R. Fojt, P. Prodanov, K. Kremenova, H. Malikova, T. Peisker, P. Stros, K. Curila, A. Javurkova, J. Raudenska, P. Budera
- 520 9_
- $a OBJECTIVES: This study sought to comprehensively determine the procedural safety and midterm efficacy of hybrid ablations. BACKGROUND: Hybrid ablation of atrial fibrillation (AF) (thoracoscopic ablation followed by catheter ablation) has been used for patients with nonparoxysmal AF; however, accurate data regarding efficacy and safety are still limited. METHODS: Patients with nonparoxysmal AF underwent thoracoscopic, off-pump ablation using the COBRA Fusion radiofrequency system (Estech) followed by a catheter ablation 3 months afterward. The safety of the procedure was assessed using sequential brain magnetic resonance and neuropsychological examinations at baseline (1 day before), postoperatively (2-4 days for brain magnetic resonance imaging or 1 month for neuropsychological examination), and at 9 months after the surgical procedure. Implantable loop recorders were used to detect arrhythmia recurrence. Arrhythmia-free survival (the primary efficacy endpoint) was defined as no episodes of AF or atrial tachycardia while off antiarrhythmic drugs, redo ablations or cardioversions. RESULTS: Fifty-nine patients (age: 62.5 ± 10.5 years) were enrolled, 37 (62.7%) were men, and the mean follow-up was 30.3 ± 10.8 months. Thoracoscopic ablation was successfully performed in 55 (93.2%) patients. On baseline magnetic resonance imaging, chronic ischemic brain lesions were present in 60.0% of patients. New ischemic lesions on postoperative magnetic resonance imaging were present in 44.4%. Major postoperative cognitive dysfunction was present in 27.0% and 17.6% at 1 and 9 months postoperatively, respectively. The probability of arrhythmia-free survival was 54.0% (95% CI: 41.3-66.8) at 1 year and 43.8% (95% CI: 30.7-57.0) at 2 years. CONCLUSIONS: The thoracoscopic ablation is associated with a high risk of silent cerebral ischemia. The midterm efficacy of hybrid ablations is moderate.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antiarytmika $x terapeutické užití $7 D000889
- 650 12
- $a fibrilace síní $x farmakoterapie $x chirurgie $7 D001281
- 650 12
- $a katetrizační ablace $x škodlivé účinky $7 D017115
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a supraventrikulární tachykardie $x chirurgie $7 D013617
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Herman, Dalibor $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kacer, Petr $u Department of Cardiac Surgery, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Rizov, Vitalii $u Department of Cardiac Surgery, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Vesela, Jana $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Rakova, Radka $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Karch, Jakub $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0273614
- 700 1_
- $a Sušánková, Markéta $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0273623
- 700 1_
- $a Znojilová, Lucie $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0273622
- 700 1_
- $a Fojt, Richard $u Department of Cardiac Surgery, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Prodanov, Petko $u Department of Cardiac Surgery, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kremeňová, Karin $u Department of Radiology, University Hospital Kralovske Vinohrady Third Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0332041
- 700 1_
- $a Malikova, Hana $u Department of Radiology, University Hospital Kralovske Vinohrady Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Peisker, Tomas $u Department of Neurology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Stros, Petr $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Curila, Karol $u Department of Cardiology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Javurkova, Alena $u Department of Clinical Psychology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Psychology, Faculty of Arts, Charles University, Prague, Czech Republic
- 700 1_
- $a Raudenska, Jaroslava $u Department of Clinical Psychology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Psychology, Faculty of Arts, Charles University, Prague, Czech Republic
- 700 1_
- $a Budera, Petr $u Department of Cardiac Surgery, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00193518 $t JACC. Clinical electrophysiology $x 2405-5018 $g Roč. 7, č. 12 (2021), s. 1519-1529
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34217655 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20250506102639 $b ABA008
- 999 __
- $a ok $b bmc $g 1789443 $s 1163038
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 7 $c 12 $d 1519-1529 $e 20210630 $i 2405-5018 $m JACC. Clinical electrophysiology $n JACC Clin Electrophysiol $x MED00193518
- LZP __
- $a Pubmed-20220425
